Back to search

Cellomatics Biosciences Limited

09782496

active
Private Limited Company
Companies House
Health Score
85 / 100

Healthy

25/30
Filing
20/30
Financial
40/40
Risk
  • No accounts filed in last 18 months (-5)

Details

10 COLWICK QUAYS BUSINESS PARK, COLWICK, NG4 2JY
Incorporated 17/09/2015

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Dr Shailendra Rambaran Singh

director · Since 17/09/2015

DIRECTOR

BRITISH · UNITED KINGDOM · Age 52

Also on 1 other board

Persons with Significant Control

Mr Ivan Everist Rozario D'Souza

25–50% shares
25–50% votes

Chinese · China · Age 61

458, Des Voeux Road West, Hong Kong

Notified 30/09/2016

Ms Susan Ivan D'Souza

25–50% shares
25–50% votes

Chinese · China · Age 55

458, Des Voeux Road West, Hong Kong

Notified 30/09/2016

Mr Shailendra Rambaran Singh

25–50% shares
25–50% votes

British · United Kingdom · Age 52

64 Wheatcroft Drive, Edwalton, NG12 4JF

Notified 15/09/2021

Former PSCs

Dr Shailendra Rambaran Singh

Ceased 30/09/2016

Charges0 outstanding

Charge
satisfied

ALFANDARI PRIVATE EQUITIES LTD

Created 05/07/2017Registered 13/07/2017Satisfied 12/10/2018

CompanyRankvs 454+ SIC 72110 peers
74

Financial strength87th percentile among SIC peers · 22/25
Employees96th percentile among SIC peers · 14/15
LiquidityCurrent ratio 1.48× · 12/20
Longevity11 years trading (max 15) · 11/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
454Cellomatics Biosciences Limited
73
How is this score calculated?
Financial strength22/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity12/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity11/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 30/09/2024

Net Worth

£343k

Balance sheet strength

Cash

£46k

Cash in the bank

Net Current Assets

£221k

Working capital

Current Assets

£685k

Current Liabilities

£464k

Fixed Assets

£130k

Debtors

£639k

18avg. employees+2

Tax at Year End(2023)

Corp tax£3k

Director Loans

Directors owe company£197k

Balance Sheet

Bank loans & overdrafts£8k
Assets less current liabilities£351k
Signed by 09782496 2023-10-01 2024-09-30 09782496 2024-09-30 09782496 bus:OrdinaryShareClass2 2024-09-30 09782496 core:CurrentFinaPrepared with Digita Accounts Production Advanced

EstimatesDerived

YearCurrent RatioImplied Profit
20241.48-£67k
20231.61-£1k
20221.91-£123k
20216.69+£87k
20202.95+£317k
20191.42+£219k
20180.46—

Derived from filed accounts. Not audited figures.